Sangamo Therapeutics Inc (NASDAQ:SGMO)

17.80
Delayed Data
As of Apr 24
 -0.35 / -1.93%
Today’s Change
4.05
Today|||52-Week Range
27.50
+8.54%
Year-to-Date
No recent news for Sangamo Therapeutics Inc.

Today’s Trading

Previous close18.15
Today’s open18.25
Day’s range17.50 - 18.58
Volume1,617,859
Average volume (3 months)2,012,871
Market cap$2.3B
Data as of 4:00pm ET, 04/24/2018

Growth & Valuation

Earnings growth (last year)+31.37%
Earnings growth (this year)+90.71%
Earnings growth (next 5 years)+24.50%
Revenue growth (last year)+88.60%
P/E ratioNM
Price/Sales35.02
Price/Book12.00

Competitors

----
EPZMEpizyme Inc-2.30-15.03%
FPRXFive Prime Therapeut...+0.55+3.34%
MNTAMomenta Pharmaceutic...-0.55-2.74%
Data as of 4:00pm ET, 04/24/2018

Financials

Next reporting dateMay 9, 2018
EPS forecast (this quarter)-$0.22
Annual revenue (last year)$36.6M
Annual profit (last year)-$54.6M
Net profit margin-149.23%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Alexander Macrae
Chief Financial Officer &
Senior Vice President
Kathy Yi
Corporate headquarters
Richmond, California

Forecasts